Inhibition of the growth of Ureaplasma urealyticum by a new urease inhibitor, flurofamide.
Flurofamide (N-[diaminophosphinyl]-4-fluorobenzamide), a urease inhibitor, was a potent inhibitor of the growth of Ureaplasma urealyticum. As little as 10 microM flurofamide (2 micrograms/ml) prevented any growth, but U. urealyticum survived for about eight hours before colony counts become undetectable. Flurofamide was a specific inhibitor of U. urealyticum since it did not inhibit growth of four Mycoplasma species or Acholeplasma hippikon. Flurofamide was 1,000 times more active than acetohydroxamic acid and thus has promise as a chemotherapeutic agent and a biochemical tool.
D000127:Acholeplasma / Q000187:drug effects; D000818:Animals; D001549:Benzamides / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D051379:Mice; D009174:Mycoplasma / Q000187:drug effects; D009180:Mycoplasmatales Infections / Q000188:drug therapy; D014509:Ureaplasma / Q000187:drug effects* / Q000254:growth & development; D014510:Urease / Q000037:antagonists & inhibitors*
D001549:Benzamides; D006877:Hydroxamic Acids; C006358:acetohydroxamic acid; C032764:flurofamide; D014510:Urease